Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
Seminars in Arthritis and Rheumatism|January 18, 2024
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?Laura E Eades, Jason Sines, Alberta Y Hoi, et al.
Immunology and Cell Biology|March 8, 2006
IL-18 is redundant in T-cell responses and in joint inflammation in antigen-induced arthritisLeilani L Santos, Georgia P Milenkovski, Pamela H Hall, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2006
Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2Julia L Gregory, Eric F Morand, Sonja J McKeown, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 1, 2014
Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipperHuapeng Fan, Wenping Kao, Yuan H Yang, et al.
Lupus|May 12, 2021
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosusRichard Furie, Eric F Morand, Anca D Askanase, et al.
Medical Teacher|January 23, 2018
Medical student psychological distress and academic performanceClaire Dendle, Julie Baulch, Rebecca Pellicano, et al.
Arthritis and Rheumatism|May 25, 2010
Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritisElaine Beaulieu, Devi Ngo, Leilani Santos, et al.
Frontiers in Immunology|June 23, 2018
Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus ErythematosusRachel Mende, Fabien B Vincent, Rangi Kandane-Rathnayake, et al.
Rheumatology (Oxford, England)|February 29, 2020
Attainment of treat-to-target endpoints in SLE patients with high disease activity in the atacicept phase 2b ADDRESS II studyEric F Morand, David A Isenberg, Daniel J Wallace, et al.
Pageof 25